“Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial” (2026) Link Medical Journal, 4(1), pp. 1–9. doi:10.61919/061x6w21.